+ All Categories
Home > Documents > PowerPoint Presentation

PowerPoint Presentation

Date post: 09-Dec-2014
Category:
Upload: pammy98
View: 1,173 times
Download: 1 times
Share this document with a friend
Description:
 
Popular Tags:
32
1 Bi 1 “Drugs and the Brain” Lecture 21 Thursday, May 11, 2006 Cystic Fibrosis: A Genetic Disease Today’s Bi 1 teaser: a best-selling biotech product. There’s a hint in the lecture hall !
Transcript
Page 1: PowerPoint Presentation

1

Bi 1 “Drugs and the Brain”

Lecture 21

Thursday, May 11, 2006Cystic Fibrosis: A Genetic Disease

Today’s Bi 1 teaser: a best-selling biotech product.

There’s a hint in the lecture hall !

Page 2: PowerPoint Presentation

2

1. Clinical description

2. Genetics

3. Gene structure

4. CFTR as a protein

5. Physiology of CFTR

6. What’s wrong with F508?

7. The cholera connection

8. Selective advantage of CF?

9. Therapeutic approaches:Incremental approachesGene therapy

Page 3: PowerPoint Presentation

3

gall bladder

common bile duct

cystic ductbecomesfibrotic(invaded by fibrous tissue)

1. Clinical Picture of cystic fibrosis

Skin is salty (usually the first sign).

Thick, sticky mucous covers the respiratory tractand digestive tract.

Respiratory infections.

Until recently, patients rarely survived childhood.

Males infertile

small intestine

Page 4: PowerPoint Presentation

4

CF is the most common autosomal recessive disease in northwestern European populations.

The chromosome frequency is ~ 1/40:

One person in 20 carries a defective CF gene and is a heterozygote (WT / defective CF).

CF

CF

CF phenotype

homozygousCF

CF

WT

normal phenotype

heterozygous“carrier”

CF

WT

normal phenotype

heterozygous“carrier”

WT

WT

normal phenotype

homozygousnormal

heterozygousmutant mother

“carrier”

CF

WT

normal phenotype

heterozygousmutant father

“carrier”

CF

WT

normal phenotype

1 marriage in 400 involves 2 heterozygotes

noncomplementation:1 birth in 1600 has CF

like Lecture 202. CF Genetics

Page 5: PowerPoint Presentation

5

3. Gene structure (discovered in 1989)

Long arm of chromosome 7

(from Lecture 20)

6a,b 14a,b 17a,b

alternatively spliced exons

250 kb in length

27 exons, 1480 amino acids = 4440 nt coding region (only 2% of the gene!)

Page 6: PowerPoint Presentation

6

4. The Protein Encoded by the Cystic Fibrosis Gene: Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)

A Cl- channel2 sets of 6 transmembrane domains

2 “ATP-binding cassettes” (thus “ABC transport protein”)

N

CR-domain

Cl- out

in

unique among channels and ABC transporters

ATP ATP

Page 7: PowerPoint Presentation

7

from Lecture 6

The Nobel Prize announcement for the patch clamp highlighted cystic fibrosis

http://www.nobel.se/medicine/laureates/1991/press.html

Press release for 1991 Nobel Prize in Physiology or Medicine:

Page 8: PowerPoint Presentation

8

Until 2002, we had only guesses about the atomic-scale structures of ABC transport proteins

R

Big Alberts 11-16© Garland Publishing

Page 9: PowerPoint Presentation

9

http://www.sciencemag.org/cgi/content/full/296/5570/1091

Kaspar P. Locher,* Allen T. Lee, Douglas C. Rees*

Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91125, USA

Science 296, p.1091 (2002)you must be “functionally” on campus

you must have Swiss-protein viewer

http://www.its.caltech.edu/~lester/Bi-1/abc-protein.pdb

The E. coli BtuCD Structure:

A Framework for ABC Transporter Architecture and Mechanism

Page 10: PowerPoint Presentation

10

cytosol

kinase

phosphorylated protein is an ion channel

cAMPCa2+

intracellularmessenger

receptor

tsqiG protein

enzymechannel effector

from Lectures 12, 14

Page 11: PowerPoint Presentation

11

Gs

Enzymes are Gq, Gs, and Gt protein effectors

cyclic AMP (cAMP)ATP

N

NN

N

NH2

O

OHO

HH

O

P-O

O

cyclic AMP (cAMP)

N

NN

N

NH2

O

OHOH

HHCH2

H

OP

O-

O

OP

O-

O

-O OP

O-

OMg2+

ATP

Enzyme“cyclase”

Mg2+

receptor

tsqiG protein

cAMPCa2+

intracellularmessenger

enzymechannel effector

from Lecture 12

Page 12: PowerPoint Presentation

12

Ca2+ or cAMP binds to kinase;this activates the kinase as an enzyme.

The enzyme catalyzes:

ATP to ADPTarget protein

Phosphate attached toa specific amino-acid side chainof the target protein

kinase

phosphorylatedprotein

is an ion channel

cAMPCa2+

intracellularmessenger

modified from from Lecture 15

Page 13: PowerPoint Presentation

13

serine

tyrosine

NH

CHC

CH2

O

O

NH

CHC

CH2

O

O

-O OP

O

O

-O OP

O

O

NH

CHC

CH2

O

O

NH

CHC

CH2

O

O

OH

OH

kinase

phosphatase

otherkinases

otherphosphatases

kinase

phosphorylatedprotein

is an ion channel

cAMPCa2+

intracellularmessenger

from Lecture 15

Page 14: PowerPoint Presentation

14

N

C

R-domain

out

in

ATPATP

cAMP-activatedprotein kinase

Expression in frog eggs shows that . . .

CFTR is a Cl- channel activated by phosphorylation and by ATP breakdown

Page 15: PowerPoint Presentation

15

N

C

Cl- out

in

-O

OP

O

O

-O

OP

O

O-O

OP

O

O

O-

OP

O

OO-

OP

O

O

R-domain

ADP ADP

Expression in frog eggs shows that . . .

CFTR is a Cl- channel activated by phosphorylation and by ATP breakdown

Page 16: PowerPoint Presentation

16

Excised “inside-out” patch allows access to the inside surface of the membrane

no additions no channel openings

CFTR is a Cl- channel activated by phosphorylation and by ATP breakdown

Like Lecture 12

cAMP-activatedprotein kinase

+ATP

closed

open

cAMP-activatedprotein kinase

+ATP

Cell expressing CFTR

Page 17: PowerPoint Presentation

17

cytosol

How fast?10 s

kinase

phosphorylated protein is an ion channel

cAMPCa2+

intracellularmessenger

receptor

tsqiG protein

enzymechannel effector

from Lectures 12, 15

Page 18: PowerPoint Presentation

18

Na+ Na+ 1. Na+ channels are usually open, but extensive Na+ flux requires a counterion.

Cl-

2. If CFTR is open, Cl- becomes the counterion. Therefore NaCl flows across the membrane.

Cl-

4. Result: isotonic NaCl solution flows from the blood to the lumen (or vice-versa)

3. Water then flows around the cells to maintain osmotic pressure.

water

the blood surface is usually quite permeable to ions

lumen“apical”surface

CFTR helps to control bulk water flow across epithelia

Epithelium: layer of cells closely bound to one another to form a continuous sheet.

Page 19: PowerPoint Presentation

19

1. coilThe osmotic gradient favors secretion of salt.“Primary” sweat is isotonic.

2. ducta. A Na+ pump in the blood-facing membrane keeps

the intracellular Na+ low. b. This attracts Na+ and Cl- out of the lumen when

CFTR is activated. c. But the tight junctions don’t allow water flow. d. Result: the sweat is depleted of salt.

sweat gland

Horse can’t dilute their sweat.This explains how humans can run marathons, but horses can’t.

This explains how CF patients have salty sweat.

Page 20: PowerPoint Presentation

20

The most common mutation (70% of mutants):a single-codon (3-nt) deletion at position 508

in ATP-binding cassette #1.A phenylalanine (F) is deleted.

N

CR-domain

Cl- out

in

6. What’s wrong with F508?

Page 21: PowerPoint Presentation

21

WT CFTR

CFTR-F508

CFTR-F508 does not usually reach the cell membrane;

but under special conditions, CFTR-F508 does reach the cell membrane and functions correctly!

Page 22: PowerPoint Presentation

22

cytosol

kinase

phosphorylated protein is an ion channel

cAMPCa2+

intracellularmessenger

receptor

tsqiG protein

enzymechannel effector

7. Cholera toxin bypasses receptors and highjacks the Gs pathway

Cholera is a bacterial disease of the intestines. Cholera and related diseases produce a toxin that enters cells.

Page 23: PowerPoint Presentation

23GTP GDP + Pi

Effector: enzyme

outside

inside

Neurotransmitter or hormonebinds to receptor

activatesG protein

The G Protein-Coupled Receptor Pathway

Cholera toxin blocks the GTPase of the subunit of Gs. The result: Gs is permanently activated.

Page 24: PowerPoint Presentation

24

Cholera patients lose salt and water through their intestines because CFTR is

constantly open.

This has caused death during past cholera epidemics.

Modern cholera therapy began (~ 1965) when physicians realized that they could

force the fluid/salt secretion pathway to function in reverse by feeding patients large

quantities of isotonic solutions. This therapy is required for a few days, until the

patient can mount an effective defense against the cholera bacteria.

The World Health Organization has developed a special “ideal” isotonic solution of

NaCl, dextrose, and other inexpensive small molecules.

However, if the WHO solution is not available, most experts recommend . . .

Isotonic popular drinks.

Page 25: PowerPoint Presentation

25

CF is so destructive in the homozygote that many people have postulated a

selective advantage for the heterozygote.

This advantage would balance the lethality of the the homozygote and would

explain how the CF mutations have not been eliminated by natural selection.

CF may protect against cholera and related diseases.

8. Selective advantage of the CF gene

Page 26: PowerPoint Presentation

26

Therefore we set 0)1(2 2 ppsp , and we find that 212 ppps . Thus the steady-state proportion of CF heterozygotes equals twice the “advantage” enjoyed by heterozygotes. We may suggest that at some point in the past, roughly 2.5% more CF heterozygotes lived to reproductive age than did WT homozygotes.

WT / WT WT / CF CF / CF

fraction of offspring before selection

incremental offspring after selection

Formal analysis of “heterozygote advantage”: Let s = the increased fraction of offspring that are produced by the CF heterozygote; but 0 = the number of offspring produced by the CF homozygote. p = the fraction of the population with CF chromosomes (~ 0.05)

( p << 1; it’s hard to imagine a mechanism that would confer a great selective advantage to the heterozygote while remaining lethal for the homozygote).

2)1( p )1(2 pp 2p

0 )1(2 psp 2p

Hardy-Weinberg law, 1908

Page 27: PowerPoint Presentation

27

The CF mutations--some 500 throughout the gene--are restricted primarily to northern European populations.

What is the explanation?

Page 28: PowerPoint Presentation

28

All I really need to know about lifeI learned in Bi 1

1. If you want a job done right, get a protein

2. Electrical circuits explain many processes

3. Most processes follow an exponential time course

4. Most processes end with a Gaussian distribution

5. Optics can show lots of details

6. Some drugs produce quasi-permanent changes in gene activation

7. Some diseases are inherited

8. Osmosis explains many processes

Page 29: PowerPoint Presentation

29

a. Enzyme replacement tablets for the digestive enzymes that do not reach the digestive tract.

b. DNAse and other tactics to minimize the bacterial infections of the airways.

c. Gene therapy to replace CFTR.

Goal: a virus should deliver (your favorite gene), and only (your favorite gene) into the target cell, without

(1) monopolizing host protein synthesis(2) replicating uncontrollably(3) inducing immunological reactions

Adenovirus (a cold virus) seems most promising.

(1) 35 kb, a manageable size(2) enters a variety of cells, especially in the respiratory tract(3) expresses genes even in nondividing cells

9. How close is a “cure” for CF?

Page 30: PowerPoint Presentation

30

1. Clinical description

2. Genetics

3. Gene structure

4. CFTR as a protein

5. Physiology of CFTR

6. What’s wrong with F508?

7. The cholera connection

8. Selective advantage of CF?

9. Therapeutic approaches:Incremental approachesGene therapy

Page 31: PowerPoint Presentation

31

Contributions to CF research have come from

bacteriavirusesfrogs and frog eggsrats micefruit fliesyeasthealthy peoplepatients

Merlin as a model for biological advances?

The Sword in the Stonehttp://www.amazon.com/exec/obidos/ASIN/0399225021/qid=958102821/sr=1-5/102-9056065-8068845

Newton as a model for scientific advances?

Page 32: PowerPoint Presentation

32

Bi 1 “Drugs and the Brain”

End of Lecture 21


Recommended